Literature DB >> 1503456

In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method.

M T Blanco1, C Pérez-Giraldo, J Blanco, F J Morán, C Hurtado, A C Gómez-García.   

Abstract

Different criteria (the drug concentration which inhibited 50% of growth [IC1/2], the lowest drug concentration at which growth was just less than 30% of that in a positive control well [IC30], the visual inhibitory concentration [ICv], and the minimum fungicidal concentration [MFC]) were applied to study the effects of some antifungal agents against Candida albicans. Amphotericin B, flucytosine, and bifonazole produced total growth inhibition. Clotrimazole, itraconazole, ketoconazole, and miconazole produced partial growth inhibition. The values of IC1/2 and IC30 were similar for all agents and avoided the problems of partial inhibition; the values of ICv and MFC were higher than those of IC1/2 and IC30.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1503456      PMCID: PMC189484          DOI: 10.1128/AAC.36.4.898

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Improved method for azole antifungal susceptibility testing.

Authors:  M A Gordon; E W Lapa; P G Passero
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

2.  Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents.

Authors:  M A Pfaller; S Wey; T Gerarden; A Houston; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jan-Feb       Impact factor: 2.803

Review 3.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus.

Authors:  H C Korting; M Ollert; A Georgii; M Fröschl
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

5.  Laboratory evaluation of antifungal agents: a comparative study of five imidazole derivatives of clinical importance.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  1980-11       Impact factor: 5.790

6.  In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.

Authors:  K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

7.  Collaborative investigation of variables in susceptibility testing of yeasts.

Authors:  M A Pfaller; M G Rinaldi; J N Galgiani; M S Bartlett; B A Body; A Espinel-Ingroff; R A Fromtling; G S Hall; C E Hughes; F C Odds
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

8.  Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates of Candida species.

Authors:  E D Spitzer; S J Travis; G S Kobayashi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

9.  Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.

Authors:  C E Hughes; R L Bennett; I C Tuna; W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

10.  Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.

Authors:  M F Mazens; G P Andrews; R C Bartlett
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

View more
  10 in total

1.  Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods.

Authors:  C Llop; I Pujol; C Aguilar; J Sala; D Riba; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  [Validation of an automatic test system for sterile testing of amniotic membranes].

Authors:  H Thomasen; K-P Steuhl; D Meller
Journal:  Ophthalmologe       Date:  2014-05       Impact factor: 1.059

3.  Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole.

Authors:  M H Nguyen; C Y Yu
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Candida albicans adhesion to and invasion and damage of vaginal epithelial cells: stage-specific inhibition by clotrimazole and bifonazole.

Authors:  Betty Wächtler; Duncan Wilson; Bernhard Hube
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

Review 5.  Antifungal susceptibility testing.

Authors:  J H Rex; M A Pfaller; M G Rinaldi; A Polak; J N Galgiani
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.

Authors:  J C Garrigues; G Cadet de Fontenay; M D Linas; M Lagente; J P Seguela
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.

Authors:  F Barchiesi; M Del Poeta; V Morbiducci; F Ancarani; G Scalise
Journal:  Mycopathologia       Date:  1993-10       Impact factor: 2.574

8.  Effects of tyrosol and farnesol on Candida albicans biofilm.

Authors:  Sarra Sebaa; Zahia Boucherit-Otmani; Philippe Courtois
Journal:  Mol Med Rep       Date:  2019-02-22       Impact factor: 2.952

9.  Fungal Infected Adipose Stem Cells: The Effects of Novel Lipo-Niosome Nanoparticles Loaded with Amphotericin B and Thymus Essential Oil.

Authors:  Fardin Rahimi; Ghasem Amoabediny; Hossein Sabahi; Behrouz Zandieh-Doulabi
Journal:  Cell J       Date:  2022-07-27       Impact factor: 3.128

10.  Ex vivo decontamination of yeast-colonized dentures by iodine-thiocyanate complexes.

Authors:  Sarra Sebaa; Maxime Faltot; Sandra De Breucker; Zahia Boucherit-Otmani; Françoise Bafort; Jean-Paul Perraudin; Philippe Courtois
Journal:  Clin Cosmet Investig Dent       Date:  2018-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.